Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
60.42 EUR | -1.63% |
|
+1.07% | +4.24% |
Jul. 03 | AKZONOBEL : Debt repayment stabilises the rating | ![]() |
Jul. 03 | AKZO NOBEL NV : Jefferies reaffirms its Neutral rating | ZD |
Projected Income Statement: Akzo Nobel N.V.
Annual
Quarterly
Halfyear
Annual
Quarterly
Halfyear
Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
---|---|---|---|---|---|---|---|---|
Net sales 1 | 8,530 | 9,587 | 10,846 | 10,668 | 10,711 | 10,598 | 10,825 | 11,157 |
Change | - | 12.39% | 13.13% | -1.64% | 0.4% | -1.06% | 2.14% | 3.07% |
EBITDA 1 | 1,442 | 1,436 | 1,157 | 1,429 | 1,478 | 1,514 | 1,636 | 1,745 |
Change | - | -0.42% | -19.43% | 23.51% | 3.43% | 2.41% | 8.09% | 6.68% |
EBIT 1 | 1,099 | 1,092 | 789 | 1,074 | 1,113 | 1,155 | 1,262 | 1,361 |
Change | - | -0.64% | -27.75% | 36.12% | 3.63% | 3.78% | 9.29% | 7.82% |
Interest Paid 1 | -69 | -39 | -124 | -272 | -102 | -121.8 | -125.3 | -117.6 |
Earnings before Tax (EBT) 1 | 919 | 1,105 | 602 | 784 | 838 | 878 | 1,090 | 1,236 |
Change | - | 20.24% | -45.52% | 30.23% | 6.89% | 4.77% | 24.17% | 13.34% |
Net income 1 | 630 | 829 | 352 | 442 | 542 | 584.1 | 737.1 | 837 |
Change | - | 31.59% | -57.54% | 25.57% | 22.62% | 7.77% | 26.18% | 13.55% |
Announcement Date | 2/17/21 | 2/9/22 | 2/8/23 | 2/7/24 | 1/28/25 | - | - | - |
1EUR in Million
Estimates
Forecast Balance Sheet: Akzo Nobel N.V.
Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
---|---|---|---|---|---|---|---|---|
Net Debt 1 | 1,034 | 2,398 | 4,089 | 3,785 | 3,901 | 3,718 | 3,422 | 2,999 |
Change | - | 131.91% | 70.52% | -7.43% | 3.06% | -4.69% | -7.96% | -12.36% |
Announcement Date | 2/17/21 | 2/9/22 | 2/8/23 | 2/7/24 | 1/28/25 | - | - | - |
1EUR in Million
Estimates
Cash Flow Forecast: Akzo Nobel N.V.
Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
---|---|---|---|---|---|---|---|---|
CAPEX 1 | 258 | 288 | 292 | 286 | 306 | 347.6 | 352.2 | 343.1 |
Change | - | 11.63% | 1.39% | -2.05% | 6.99% | 13.59% | 1.33% | -2.59% |
Free Cash Flow (FCF) 1 | 962 | 317 | -29 | 840 | 367 | 648 | 735.1 | 896 |
Change | - | -67.05% | -109.15% | 2,996.55% | -56.31% | 76.57% | 13.44% | 21.88% |
Announcement Date | 2/17/21 | 2/9/22 | 2/8/23 | 2/7/24 | 1/28/25 | - | - | - |
1EUR in Million
Estimates
Forecast Financial Ratios: Akzo Nobel N.V.
Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
---|---|---|---|---|---|---|---|---|
Profitability | ||||||||
EBITDA Margin (%) | 16.91% | 14.98% | 10.67% | 13.4% | 13.8% | 14.28% | 15.11% | 15.64% |
EBIT Margin (%) | 12.88% | 11.39% | 7.27% | 10.07% | 10.39% | 10.9% | 11.66% | 12.2% |
EBT Margin (%) | 10.77% | 11.53% | 5.55% | 7.35% | 7.82% | 8.28% | 10.07% | 11.07% |
Net margin (%) | 7.39% | 8.65% | 3.25% | 4.14% | 5.06% | 5.51% | 6.81% | 7.5% |
FCF margin (%) | 11.28% | 3.31% | -0.27% | 7.87% | 3.43% | 6.11% | 6.79% | 8.03% |
FCF / Net Income (%) | 152.7% | 38.24% | -8.24% | 190.05% | 67.71% | 110.93% | 99.74% | 107.05% |
Profitability | ||||||||
ROA | 5.67% | 5.57% | 2.99% | 3.57% | 4.6% | 4.45% | 5.55% | 6% |
ROE | 12.27% | 13.48% | 8.77% | 12.09% | 14.91% | 13.89% | 15.93% | 16.32% |
Financial Health | ||||||||
Leverage (Debt/EBITDA) | 0.72x | 1.67x | 3.53x | 2.65x | 2.64x | 2.46x | 2.09x | 1.72x |
Debt / Free cash flow | 1.07x | 7.56x | -141x | 4.51x | 10.63x | 5.74x | 4.66x | 3.35x |
Capital Intensity | ||||||||
CAPEX / Current Assets (%) | 3.02% | 3% | 2.69% | 2.68% | 2.86% | 3.28% | 3.25% | 3.08% |
CAPEX / EBITDA (%) | 17.89% | 20.06% | 25.24% | 20.01% | 20.7% | 22.97% | 21.53% | 19.66% |
CAPEX / FCF (%) | 26.82% | 90.85% | -1,006.9% | 34.05% | 83.38% | 53.64% | 47.91% | 38.29% |
Items per share | ||||||||
Cash flow per share 1 | 6.374 | 3.27 | 1.505 | 6.6 | 6.249 | 5.602 | 5.982 | 6.636 |
Change | - | -48.69% | -53.97% | 338.43% | -5.32% | -10.35% | 6.78% | 10.93% |
Dividend per Share 1 | 1.95 | 1.98 | 1.98 | 1.98 | 1.98 | 1.98 | 2.059 | 2.157 |
Change | - | 1.54% | 0% | 0% | 0% | -0% | 4.01% | 4.76% |
Book Value Per Share 1 | 30.02 | 29.32 | 24.8 | 25.33 | 26.81 | 28.13 | 30.23 | 33.19 |
Change | - | -2.32% | -15.42% | 2.14% | 5.83% | 4.92% | 7.46% | 9.79% |
EPS 1 | 3.32 | 4.46 | 2.01 | 2.59 | 3.17 | 3.54 | 4.517 | 5.134 |
Change | - | 34.34% | -54.93% | 28.86% | 22.39% | 11.69% | 27.57% | 13.68% |
Nbr of stocks (in thousands) | 192,726 | 182,386 | 177,400 | 170,595 | 170,779 | 170,900 | 170,900 | 170,900 |
Announcement Date | 2/17/21 | 2/9/22 | 2/8/23 | 2/7/24 | 1/28/25 | - | - | - |
1EUR
Estimates
2025 * | 2026 * | |
---|---|---|
P/E ratio | 17.1x | 13.4x |
PBR | 2.15x | 2x |
EV / Sales | 1.33x | 1.27x |
Yield | 3.28% | 3.41% |
More valuation ratios
* Estimated data
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Sell
Buy

Mean consensus
OUTPERFORM
Number of Analysts
19
Last Close Price
60.42EUR
Average target price
69.78EUR
Spread / Average Target
+15.49%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- AKZA Stock
- Financials Akzo Nobel N.V.
Select your edition
All financial news and data tailored to specific country editions